1. Poster Abstract from ID Week 2016 – Reducing SSIR Rates with Nozin Nasal Sanitizer

    January 27, 2017

    Baylor Orthopedic and Spine Hospital at Arlington, Texas presented a poster at ID Week 2016: Pre- and Post-Operative Participation of Orthopedic Patients and Surgical Staff in a Novel Intervention to Reduce Staphylococcus aureus Infection. The premise of the poster abstract presentation was “overall reduction of potentially infectious bacteria in the immediate patient environment is critical to effective infection […]


  2. The Importance of Nasal Decolonization for Infection Control

    July 8, 2016

    According to the Centers for Disease Control, Hospital acquired infections (HAIs), including the infections caused by Methicillin-resistant Staphylococcus aureus (MRSA), are costing hospitals more than $30 billion per year. New federal health care rules are also reducing reimbursements to hospitals for HAI treatment. Studies show that nasal carriage plays a major role in HAI and […]


  3. Antibiotic-Preserving Strategies Must Be Implemented to Battle Resistance

    May 6, 2016

    Antibiotic resistance and development of antibiotic stewardship programs are ongoing issues for healthcare providers. The annual  “Get Smart about Antibiotics Week” developed by the Centers for Disease Control and Prevention (CDC) and other partners highlights events, educational resources, and a spotlight for organizations to coordinate strategies around stewardship programs and the overuse and misuse of antibiotics. Press Release […]


  4. ASU Team Develops Quick Way to Determine Bacteria’s Antibiotic Resistance

    September 4, 2015

    Bacteria’s ability to become resistant to antibiotics is a growing issue in health care: Resistant strains result in prolonged illnesses and higher mortality rates.One way to combat this is to determine bacteria’s antibiotic resistance in a given patient, but that often takes days — and time is crucial in treatment. ASU scientists have developed a […]



Health Professionals:
Request a comprehensive analysis of your colonization risk mitigation protocols today.

© 2004-2023 Global Life Technologies Corp. All rights reserved. All trademarks are property of their respective owners. Nozin® Nasal Sanitizer® antiseptic is an OTC topical antiseptic drug and no claim is made that it has an effect on any specific disease. | Patent Nos.